Syndecan-3 modulates food intake by interacting with the melanocortin/AgRP pathway

Annals of the New York Academy of Sciences

Volumn 994, Issue , 2003, Pages 66-73

  Reizes, Ofer ^a   Benoit, Stephen C ^b   Strader, April D ^b   Clegg, Deborah J ^b   Akunuru, Shailaja ^a   Seeley, Randy J ^b  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Heparan sulfate proteoglycan; Metalloprotease inhibitor; Syndecan

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ALPHA INTERMEDIN ANTAGONIST; HORMONE ANTAGONIST; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; METALLOPROTEINASE INHIBITOR; MT II; PROTEOHEPARAN SULFATE; SYNDECAN; SYNDECAN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY FAT; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY BALANCE; ENZYME INHIBITION; FEEDING BEHAVIOR; FOOD DEPRIVATION; FOOD INTAKE; MELANOCORTIN SYSTEM; MEMBRANE BINDING; MODULATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINE SYSTEM; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENICS;

AGOUTI; ANIMALIA;

EID: 0038727647     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03163.x     Document Type: Conference Paper

References (26)

1. CROWLEY, V.E., G.S. YEO & S. O'RAHILLY. 2002. Obesity therapy: altering the energy intake-and-expenditure balance sheet. Nat. Rev. Drug Discovery 1: 276-286.
2. PORTE, D., JR., R.J. SEELEY, S.C. WOODS, et al. 1998. Obesity, diabetes and the central nervous system. Diabetologia 41: 863-881.
3. SCHWARTZ, M.W., S.C. WOODS, D. PORTE, JR., et al. 2000. Central nervous system control of food intake. Nature 404: 661-671.
4. SEELEY, R.J. & M.W. SCHWARTZ. 1999. Neuroendocrine regulation of food intake. Acta Paediatr. Suppl. 88: 58-61.
5. WEIGLE, D.S. 1994. Appetite and the regulation of body composition. FASEB J. 8: 302-310.
6. SCHWARTZ, M.W., M.F. DALLMAN & S.C. WOODS. 1995. Hypothalamic response to starvation: implications for the study of wasting disorders. Am. J. Physiol. 269: 949-957.
7. HALFORD, J.C. & J.E. BLUNDELL. 2000. Pharmacology of appetite suppression. Prog. Drug Res. 54: 25-58.
8. HAVEL, P.J. 2001. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp. Biol. Med. (Maywood) 226: 963-977.
9. FLIER, J.S. & E. MARATOS-FLIER. 1998. Obesity and the hypothalamus: novel peptides for new pathways. Cell 92: 437-440.
10. SPIEGELMAN, B.M. & J.S. FLIER. 2001. Obesity and the regulation of energy balance. Cell 104: 531-543.
11. BERNFIELD, M., M. GÖTTE, P.W. PARK, et al. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68: 729-777.
12. PARK, P.W., O. REIZES & M. BERNFIELD. 2000. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 275: 29923-29926.
13. GALLAGHER, J.T. & J.E. TURNBULL. 1992. Heparan sulfate in the binding and activation of basic fibroblast growth factor. Glycobiology 2: 523-528.
14. RAPRAEGER, A.C. 1995. In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? Chem. & Biol. 2: 645-649.
15. CONRAD, H.E. 1998. Heparin-Binding Proteins. Academic Press. San Diego.
16. REIZES, O., J. LINCECUM, Z. WANG, et al. 2001. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106: 105-116.
17. OLLMANN, M.M., B.D. WILSON, Y.-K. YANG, et al. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138.
18. SHUTTER, J.R., M. GRAHAM, A.C. KINSEY, et al. 1997. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes & Dev. 11: 593-602.
19. FAN, W., B.A. BOSTON, R.A. KESTERSON, et al. 1997. Role for melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168.
20. FITZGERALD, M.L., Z. WANG, P.W. PARK, et al. 2000. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 148: 811-824.
21. BLOBEL, C.P. 2000. Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 12: 606-612.
22. SCHLONDORFF, J. & C.P. BLOBEL. 1999. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell Sci. 112: 3603-3617.
23. BREW, K., D. DINAKARPANDIAN & H. NAGASE. 2000. Tissue inhibitors of metallo-proteinases: evolution, structure and function. Biochim. Biophys. Acta 1477: 267-283.
24. NAGASE, H. & K. BREW. 2002. Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics. Arthritis Res. 4: S51-S61.
25. HAGAN, M.M., P.A. RUSHING, L.M. PRITCHARD, et al. 2000. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279: 47-52.
26. HAGAN, M.M., S.C. BENOIT, P.A. RUSHING, et al. 2001. Immediate and prolonged patterns of agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology 142: 1050-1056.